Objectives: This study aimed to explore the period between onset of pain and hospital-admission (pain-to-admission time) in patients with acute pancreatitis (AP), to investigate the prognostic value and associated factors of this time, and to ascertain the knowledge about the pancreas in these patients.
A cute pancreatitis (AP) is a severe and potential lifethreatening disease with an incidence of 19.7 to 42.8/ 100,000/y. 1, 2 Although approximately 85% of AP episodes are mild and self-limiting, severe cases have a mortality of up to 42%. 3, 4 The diagnosis is based on typical clinical symptoms and laboratory tests. 5 Early diagnosis and immediate therapyV elimination of the causing agent, intravenous fluid replacement, and analgesicsVare of high importance in the management of AP. 5Y9 To be able to start therapy timely, the patient has to recognize AP-induced pain, to appropriately estimate pain severity, and to show up in the emergency department as soon as possible. The pain-to-admission time might be shortened if the patient has knowledge of the existence of the pancreas, where the pancreas is located, that the pancreas can get inflamed, can cause pain, and that this is a good reason to consult a physician.
The aim of this extended analysis of a previously published prospective study on AP was to determine the period between onset of pain and admission to the hospital (pain-to-admission time) in patients experiencing AP and to determine the influencing factors associated with the delay as well as the prognostic value of this period. A further aim was to investigate the knowledge about the pancreas and AP in hospitalized patients experiencing AP.
MATERIALS AND METHODS
This is an extended analysis of data from a prospective multicenter study by our group on the incidence of AP. 2 Evaluation of the patients' first symptoms, knowledge on AP, initial management, and pain-to-admission time were a priori end points of the prospective multicenter PROST (Pancreatitis during Oktoberfest) study. This was a prospective study of 188 patients with AP, treated at 27 hospitals in the greater area of Munich, Germany (2,970,000 inhabitants) during the 2008 Oktoberfest and showed that the incidence of AP does not rise during the world's largest beer fair compared with two 18-day control periods but is higher than previously described in Germany. All patients admitted to the hospital because of AP were interviewed using a questionnaire. They were asked about the onset of pain, about their own explanation of the symptoms, and their personal measures against their complaints. The painto-admission time was rounded to the nearest hour. Additionally, patients were explored if they ever had heard about AP, and if they thought AP was a dangerous disease. Pain level was measured on a scale from 0 (no pain) to 10 (maximal pain).
Statistical Analysis
Statistical analyses were performed using IBM SPSS Statistics software (version 19, SPSS Inc, Chicago, Ill). Descriptive data are presented as median and interquartile range (IQR). In case of missing values, proportions were calculated based on the number of valid data. To compare quantitative data between 2 independent subgroups, Mann-Whitney U test was performed. Spearman correlation coefficient (r) was calculated to assess bivariate relationship of ordinal or continuous parameters. Parameters with a P G 0.1 in univariable analysis and a limited number of factors with high probability of impact were considered for multivariable logistic regression analyses regarding dichotomous end points. To assess the discriminative ability of the resulting regression models, the concordance index (c-index = area under the curve) was calculated based on the resulting predicted probabilities by a receiver operating characteristics analysis. Piecewise log-linear models were used to assess relative impact of ordinal-or quantitative data on right-skewed outcome variables as pain-to-admission time. All statistical tests performed were 2-sided and a P G 0.05 was considered to indicate statistical significance.
RESULTS

Patients' Characteristics
Patients' characteristics are shown in Table 1 . Of the 188 patients, 128 (68%) answered all questions about their knowledge on the pancreas and AP.
Pain Level
In general, patients experienced severe pain. The median pain level on a scale from 0 to 10 was 8.0 (IQR, 7.0Y10.0) on hospital admission. Distribution of the pain levels is shown in Figure 1 . There was a weak but statistically significant inverse correlation between age and pain level (r = j0.26; P = 0.002).
Pain-to-Admission Time
The median pain-to-admission time was 27 hours (range, 0Y672; IQR, 6.0Y72.0 hours). Despite marked pain, only 50% of patients were admitted to the hospital within 24 hours after onset of pain (Fig. 2) . For pain levels greater or equal than 6, the pain-to-admission time significantly decreased with increasing pain level [decrease for each 1-U pain level, 27%; 95% confidence interval (CI), 59%Y89%; P = 0.003] (see Fig. 1 , Supplemental Digital Content 1, http://links.lww.com/MPA/A203).
Univariable comparison of the pain-to-admission time revealed no significant differences between the categories of the parameters sex (P = 0.407), etiology (alcoholic, P = 0.262; biliary, P = 0.593), principal residence (city of Munich or surrounding area, P = 0.618), and the knowledge that AP is a potential fatal disease (P = 0.250).
Prognostic Factors on Hospital Presentation
C-Reactive Protein
Low values of C-reactive protein (CRP) on admission were associated with short pain-to-admission time (r = +0.334; P G 0.001). Furthermore, low values of CRP on admission weakly correlated with high pain intensity (r = j0.208; P = 0.021). The median time from onset of pain to maximum value of CRP was 3 days (IQR, 2Y5 days; Fig. 3A) . The highest maximum values of CRP were also observed around day 3 after onset of pain (Fig. 3B ). The median of maximum CRP values was 13.9 mg/dL (IQR, 3.3Y26.2 mg/dL).
Lipase
Whereas patients with early presentation had lower CRP levels (see previously mentioned), short pain-to-admission time correlated with higher serum values of lipase on admission (r = j0.226; P = 0.019). In 38/110 (35%) patients, the highest value of serum lipase was measured within the first day after onset of pain ( 
Prognostic Value of the Pain-to-Admission Time in Association With CRP and Serum Lipase
The pain-to-admission time was significantly shorter in intensive care unit (ICU) patients (10 hours) compared to non-ICU patients (36 hours; P = 0.045). Where applicable, data are presented as median with IQR (25thY75th percentile); otherwise, number (%). There was an inappropriate discriminative performance of the single parameters CRP (c-index, 0.50) and lipase (c-index, 0.64) for the prediction of ICU admission. However, because relevant time dependencies were apparent in the descriptive analysis, an additional impact of the pain-to-admission time (c-index, 0.63) on the predictive performance of these markers was hypothesized. Therefore, a multiple logistic regression analysis including the admission values for CRP and serum lipase and the corresponding interactions to the pain-to-admission time was performed. This interaction model showed a substantial 
Patients' Suspected Diagnosis and Self-Therapy
The most frequent causes of pain suspected by the patients were diseases of the stomach/bowel (52/127, 41%). Only 29/127 (23%) of the patients associated their complaints to any affection of the pancreas. Of the 127 patients who answered this question, 9 (7%) suspected an impairment of the liver, 21 (17%) suspected various extraintestinal disorders, and 16 (13%) patients had ''no idea'' at all. Of the 137 patients, 72 (53%) did not start any therapy on their own, 52 (38%) took some kind of drugs. Among these, 33 (24%) used pain reliever, 12 (9%) proton pump inhibitors, 8 (6%) used butylscopolamine, and 8 (6%) took other drugs (multiple answers possible); 13 (10%) used nonpharmacological therapies including tea drinking and hot-water bag.
Knowledge About the Pancreas and Pancreatitis
Of the 130 patients who answered the questions about their knowledge on the pancreas and AP, 112 (86%) were aware that they have a pancreas; of the 128 patients, 80 (63%) knew the correct anatomic position and 69 (54%) also knew the right physiological function of this organ. Regarding AP, 81/112 (72%) of the patients who knew that they have a pancreas were aware of this disease and 45/81 (56%) of those patients recognized that this is a potentially severe and fatal disease.
In univariate analysis, patients with a first-degree relative experiencing a pancreatic disease knew significantly more often that they have a pancreas compared to patients without pancreatic ill relatives [21/21 (100%) vs 88/106 (83%); P = 0.039]. Patients with diabetes mellitus significantly less often knew that they have a pancreas than patients not experiencing diabetes mellitus [15/21 (71%) vs 95/107 (89%); P = 0.043]. Etiology of AP, age, sex, residency, and recurrent attack of AP showed no substantial influence on the knowledge about the pancreas. P values are taken from the adjusted multivariable logistic regression model. In multivariable analysis including these parameters, only diabetes mellitus had a statistical significant negative influence on the knowledge about the existence of the pancreas (odds ratio, 0.254; 95% CI, 0.067Y0.967; P = 0.045).
Regarding the knowledge of the entity of AP, multivariable logistic regression analysis including the parameters sex, age, place of residence, alcoholic etiology, biliary etiology, recurrent attack of AP, family history of pancreatic disease, and diabetes mellitus showed only alcoholic etiology (odds ratio, 3.670; 95% CI, 1.236Y10.900; P = 0.019) as an independent factor to know that a disease ''acute pancreatitis'' exists.
DISCUSSION
This article provides data regarding pain-to-admission time and patients' knowledge on AP, taken from a prospective multicenter study by our group (PROST study). 2 Early prediction of severity of AP is of high importance for triage which patient has to be treated as an outpatient, inpatient, or even ICU-patient. A lot of research has been done on this subject and a lot of single parameters, for example, CRP, procalcitonin, interleukin-6, D-dimer, and serum urea nitrogen (SUN) have been suggested as predictors for disease severity. 10Y14 Because single parameters are susceptible for failure and no single parameter provides appropriate predictive capabilities, many scores have been introduced, for example, Ranson score, Balthazar CT severity index, Pancreatitis Outcome Prediction (POP) score, bedside index for severity in AP (BISAP) score, and harmless AP score (HAPS) to predict a severe or harmless course of AP. 4 ,15Y19 Furthermore, several mostly unknown scores, including artificial neural networks, have been developed. 20Y24 However, there are different shortcomings with all of them. Some parameters are not obtainable everywhere or are expensive, some scores are complex, have either a low negative predictive value (NPV) or low positive predictive value (PPV), or predict outcome not earlier than 48 hours after admission. Therefore, our study focused on early and widely available predictors including simple anamnestic data, which might be underrepresented in the current scores. According to our data, short pain-to-admission time correlates with higher probability of ICU treatment. Furthermore, short painto-admission time is associated with high pain levels, low values of CRP on admission, and high values of serum lipase on admission. Andersson et al 24 recently presented an artificial neural network model for prediction of severity of AP, including for the first time the duration of pain as one of the predicting factors and showing shorter duration of pain until arrival at the emergency department for severe cases. The primary analysis of our data showed high serum lipase values on admission, among others, as a predictor for ICU treatment. 2 Whereas CRP has shown to be a prognostic factor for severity of AP, the value of lipase frequently is considered to have diagnostic rather than predictive qualities.
25Y27 CRP and serum lipase are dependent on the duration of AP and show contrary courses: Serum lipase increases 4 to 8 hours after onset of AP and reaches a maximum at approximately 24 hours, followed by a continuous decrease for 8 to 14 days. In contrast, CRP has a delayed increase with a predictive value starting at approximately 36 hours and a maximal value at 72 to 96 hours after onset of symptoms. 10, 25 According to these findings, serum lipase should have a high PPV and NPV within the first approximately 24 hours, followed by a high PPV but low NPV. In contrast, CRP has a low NPV within the first roughly 72 hours, followed by a high NPV and high PPV after approximately 96 hours. Therefore, a combination of CRP and lipase in dependency of the time since the onset of pain might provide a useful prediction formula.
10,28Y30 Our data suggest that serum lipase and CRP on admission in dependency of the time since onset of pain is a suitable predictor for the need of ICU treatment. This underlines that predictive capabilities of several markers markedly depend on the time since onset of symptoms as previously postulated. 30 We choose ICU admission as end point because it is well defined and available for all patients, in contrast to the Atlanta severity classification or complex scores like APACHE-II, Ranson, or BISAP score. 31, 32 Furthermore, some patients might not have developed severe AP according to the Atlanta classification due to the close monitoring and intensive treatment in the ICU. Except for one patient, all patients who were transferred to the ICU had either severe AP according to the Atlanta classification (17/40; 43%) or had at least 1 well-established prognostic factor regarding severe AP on admission. These prognostic factors included the following values: serum glucose greater than 250 mg/dL in patients without diabetes mellitus (12/40; 30%), hematocrit greater than 44% (14/40; 35%), and SUN greater than 22 mg/dL on admission (23/40; 58%) or a rise of SUN within 24 hours after admission (2/40; 5%).
15,33Y35
The only exception mentioned previously was an 89-yearold lady experiencing biliary AP with cardiac events in her medical history. Therefore, all patients had a good indication to be transferred to the ICU.
In a region with unrestricted and fast access to medical service, pain-to-admission time might be mainly determined by patients' assessment of symptoms and severity of the causes supposed. Therefore, the questionnaire investigated patients' suspected etiology of complaints and their knowledge about the pancreas and AP. Several studies demonstrated that in patients with acute coronary syndrome or stroke educational campaigns resulting in better patients' awareness for early symptoms can shorten the time between appearance of first symptoms and hospital admission.
36Y38 Furthermore, shortened time between onset of symptoms and beginning treatment has been shown to improve outcome in these patients. 39, 40 Although cardiovascular diseases are much more frequent and have a higher mortality, earlier beginning of treatment in patients experiencing AP could also improve outcome in these patients. Similar to cardiovascular diseases, there isVdespite a lack of supporting dataVuniversal agreement that aggressive and early treatment (ie, fluid resuscitation) is critical in the therapy for AP. 41 Because there are no data on knowledge and awareness of early symptoms in AP, we also investigated the knowledge about the existence, anatomy, and function of the pancreas as well as early symptoms of AP. Although 86% of patients with AP knew that they have a pancreas, only 72% of these patients knew that the pancreas can get inflamed and only 56% recognized that this is a potential fatal disease. This implicates that the knowledge on the pancreas and pancreatitis is poor.
The median pain-to-admission time was 27 hours. Because early fluid resuscitation is one of the most important parts of therapy for AP, an admission to the hospital and initiation of fluid administration as soon as possible is desirable. 6Y8 A study by Brown et al 34 showed a hematocrit level greater than or equal to 44% on admission and failure of admission hematocrit to decrease at 24 hours after admission were the best predictors of necrotizing pancreatitis, also indicating the value of early therapy. Furthermore, the mostly used and most useful severity scores are calculated within the first 48 hours and patients with AP who already had an organ failure at first presentation had a significant higher mortality.
42Y44 Therefore, the painto-admission time should be shortened. Especially patients with increased risks to develop AP, for example, problem drinkers and patients with cholecystolithiasis should know about their pancreas and pancreatitis. Only patients admitted because of alcohol-induced AP, but not patients with biliary AP, knew more often that pancreatitis exists compared to patients with AP due to other reasons. This suggests that physicians fail to inform patients at the diagnosis of cholecystolithiasis about the risk of biliary AP. Assuming a prevalence of cholecystolithiasis of 20% and an incidence of biliary pancreatitis of 14.8/100,000/y in Germany, the risk of patients with cholecystolithiasis to develop an episode of biliary pancreatitis is 0.08% per year, that is, 1 of 1333 per year.
2,45Y47 We realize that this is a low number, however, considering rising life expectancy, the lifetime risk is much higher. Furthermore, biliary pancreatitis might be fatal for the individual patient and the medical education is very simple. Against our expectations, the knowledge on the pancreas in patients with diabetes mellitus was worse compared to patients without diabetes. This might be because patients experiencing diabetes focus on the endocrine function of the pancreas.
As the elimination of the causing agent is the only casual therapy for AP and a high percentage of AP is caused by immoderate alcohol intake, Takeyama 48 observed the drinking habits of patients after the first attack of AP. They found a higher risk of recurrence, progression to chronic pancreatitis, and development of diabetes in patients who maintained their drinking level compared to patients who discontinued or reduced alcohol consumption. Also, another study supports these findings. 49 In our study, 90.0% of patients with alcohol-induced AP previously had received admonitions to reduce immoderate alcohol consumption.
The efforts to improve patients' outcome are not only based on medical but also on economic reasons. Two recent US studies calculated the annual direct medical costs in the United States to $2.2 billion for AP and $3.7 billion for AP and chronic pancreatitis. 50, 51 Therefore, the awareness of the pancreas, of pancreatitis, and of the impact of alcohol consumption and smoking on the risk of acute and chronic pancreatitis must be raised in our population, especially in patients with risk factors also including cholecystolithiasis. 52 Summing up, AP is a not infrequent, potential fatal and expensive disease. The first hours of the disease seem to be the most susceptible time for effective therapy. With a median pain-to-admission time of 27 hours, the first important day is lost by the patient himself. Educational efforts on patients' awareness could shorten the pain-to-admission time and therefore gain valuable time for the therapy for AP. Especially people on risk, for example, patients with cholecystolithiasis and/or immoderate alcohol consumption, should be educated regarding AP.
There are some limitations of this study. Despite the multicenter approach of the study, it was conducted in a limited area, the observation period was only 54 days, and only 188 patients were included. We do not know the exact reasons for ICU admissions of the individual patients but all except one had a severe AP according to the Atlanta classification or at least one prognostic factor regarding a severe course. However, conclusions regarding the prognostic capability of the admission values for serum lipase and CRP and the corresponding interactions to the pain-to-admission time have to be confirmed in larger and interventional studies and different populations.
We conclude that the knowledge about AP in hospitalized AP patients is poor with an inappropriately long painto-admission time. To improve the outcome of patients with AP by starting therapy as early as possible, the pain-toadmission time should be shortened and the knowledge about AP should be improved, especially in patients at risk. Serum lipase and CRP have appropriate predictive value regarding severity of AP only when used in the context of the time since onset of pain.
